Pub Date : 2024-01-01DOI: 10.1016/j.otoeng.2023.09.001
José Manuel Morales-Puebla , Mireya Fernández-Fournier , Antoni Plana-Blanco , Luis Lassaletta
Background
Acute peripheral facial paralysis may be diagnosed and treated by different specialists.
Objective
The aim of this study was to explore the variability in the treatment of Bell’s palsy (BP) and Ramsay Hunt Syndrome (RHS) among different medical specialties.
Methods
An anonymous nationwide online survey was distributed among the Spanish Societies of Otorhinolaryngology (ORL), Neurology (NRL) and Family and Community Medicine (GP).
Results
1039 responses were obtained. 98% agreed on using corticosteroids, ORL using higher doses than NRL and GP. Among all, only 13% prescribed antivirals in BP routinely, while 31% prescribed them occasionally. The percentage of specialists not using antivirals for RHS was 5% of ORL, 11% of NRL, and 23% of GP (GP vs. NRL p = 0.001; GP vs. ORL p < 0.0001; NRL vs. ORL p = 0,002). 99% recommended eye care. Exercises as chewing gum or blowing balloons were prescribed by 45% of the participants with statistically significant differences among the three specialties (GP vs. NRL p = 0.021; GP vs. ORL p < 0.0001; NRL vs. ORL p = 0.002).
Conclusion
There is general agreement in the use of corticosteroids and recommending eye care as part of the treatment of acute peripheral facial paralysis. Yet, there are discrepancies in corticosteroids dosage, use of antivirals and recommendation of facial exercises among specialties.
背景:急性周围性面瘫可由不同的专家进行诊断和治疗。目的:本研究旨在探讨不同医学专业治疗Bell麻痹(BP)和Ramsay-Hunt综合征(RHS)的差异性。方法:一项匿名的全国性在线调查在西班牙耳鼻喉科学会(ORL)、神经病学学会(NRL)和家庭与社区医学会(GP)中进行。结果:获得1039个回复。98%的人同意使用皮质类固醇,ORL使用比NRL和GP更高的剂量。其中,只有13%的人常规服用抗病毒药物,31%的人偶尔服用。未使用抗病毒药物治疗RHS的专家比例为ORL的5%、NRL的11%和GP的23%(GP与NRL相比,p = 0.001;GP与ORL p 结论:使用皮质类固醇和推荐眼部护理作为治疗急性周围性面瘫的一部分是普遍一致的。然而,不同专业的皮质类固醇剂量、抗病毒药物的使用和面部锻炼的建议存在差异。
{"title":"Variations in the treatment of acute peripheral facial paralysis. A nationwide survey","authors":"José Manuel Morales-Puebla , Mireya Fernández-Fournier , Antoni Plana-Blanco , Luis Lassaletta","doi":"10.1016/j.otoeng.2023.09.001","DOIUrl":"10.1016/j.otoeng.2023.09.001","url":null,"abstract":"<div><h3>Background</h3><p>Acute peripheral facial paralysis may be diagnosed and treated by different specialists.</p></div><div><h3>Objective</h3><p><span>The aim of this study was to explore the variability in the treatment of Bell’s palsy (BP) and </span>Ramsay Hunt Syndrome (RHS) among different medical specialties.</p></div><div><h3>Methods</h3><p><span>An anonymous nationwide online survey was distributed among the Spanish Societies of Otorhinolaryngology<span> (ORL), Neurology (NRL) and Family and </span></span>Community Medicine (GP).</p></div><div><h3>Results</h3><p>1039 responses were obtained. 98% agreed on using corticosteroids, ORL using higher doses than NRL and GP. Among all, only 13% prescribed antivirals in BP routinely, while 31% prescribed them occasionally. The percentage of specialists not using antivirals for RHS was 5% of ORL, 11% of NRL, and 23% of GP (GP vs. NRL p = 0.001; GP vs. ORL p < 0.0001; NRL vs. ORL p = 0,002). 99% recommended eye care. Exercises as chewing gum or blowing balloons were prescribed by 45% of the participants with statistically significant differences among the three specialties (GP vs. NRL p = 0.021; GP vs. ORL p < 0.0001; NRL vs. ORL p = 0.002).</p></div><div><h3>Conclusion</h3><p>There is general agreement in the use of corticosteroids and recommending eye care as part of the treatment of acute peripheral facial paralysis. Yet, there are discrepancies in corticosteroids dosage, use of antivirals and recommendation of facial exercises among specialties.</p></div>","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"75 1","pages":"Pages 31-39"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10311188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.1016/j.otoeng.2023.06.008
Xavier León , Eduard Neumann , Anna Holgado , Rosselin Vásquez , Albert Pujol , Miquel Quer
Objective
To evaluate the possibilities of salvage after local recurrence in patients with oropharyngeal carcinomas treated with radiotherapy, and to analyse the prognostic factors related to the final control of the disease.
Methods
Retrospective study of 596 patients with oropharyngeal carcinoma treated with radiotherapy during the period 1991–2018.
Results
One hundred and eighty-one patients (30.4%) had a local recurrence. Of the patients with a local recurrence, 51 (28.2%) were treated with salvage surgery. Variables that were associated with the patient not receiving salvage surgery were age greater than 75 years, tumour location in the posterior hypopharyngeal wall, an initial tumour extent cT4, and a recurrence-free interval of less than 6 months. Five-year specific survival of patients treated with salvage surgery was 19.1% (95% CI: 7.3%–30.9%). Variables that were related to specific survival were extent of recurrence and status of resection margins. Final tumour control was not achieved in any of the patients with extensive recurrence (rpT3−4, n = 25) or positive resection margins (n = 22).
Conclusion
Patients with oropharyngeal carcinomas treated with radiotherapy with local tumour recurrence have a limited prognosis. Most patients (71.8%) were not considered candidates for salvage surgery. The 5-year specific survival of patients treated with salvage surgery was 19.1%.
{"title":"Oncological results of salvage treatment in patients with oropharynx carcinoma treated with radiotherapy","authors":"Xavier León , Eduard Neumann , Anna Holgado , Rosselin Vásquez , Albert Pujol , Miquel Quer","doi":"10.1016/j.otoeng.2023.06.008","DOIUrl":"10.1016/j.otoeng.2023.06.008","url":null,"abstract":"<div><h3>Objective</h3><p>To evaluate the possibilities of salvage after local recurrence in patients<span> with oropharyngeal carcinomas<span> treated with radiotherapy, and to analyse the prognostic factors related to the final control of the disease.</span></span></p></div><div><h3>Methods</h3><p>Retrospective study of 596 patients with oropharyngeal carcinoma treated with radiotherapy during the period 1991–2018.</p></div><div><h3>Results</h3><p>One hundred and eighty-one patients (30.4%) had a local recurrence. Of the patients with a local recurrence, 51 (28.2%) were treated with salvage surgery. Variables that were associated with the patient not receiving salvage surgery were age greater than 75 years, tumour location in the posterior hypopharyngeal wall, an initial tumour extent cT4, and a recurrence-free interval of less than 6 months. Five-year specific survival of patients treated with salvage surgery was 19.1% (95% CI: 7.3%–30.9%). Variables that were related to specific survival were extent of recurrence and status of resection margins. Final tumour control was not achieved in any of the patients with extensive recurrence (rpT3−4, <em>n</em> = 25) or positive resection margins (<em>n</em> = 22).</p></div><div><h3>Conclusion</h3><p>Patients with oropharyngeal carcinomas treated with radiotherapy with local tumour recurrence have a limited prognosis. Most patients (71.8%) were not considered candidates for salvage surgery. The 5-year specific survival of patients treated with salvage surgery was 19.1%.</p></div>","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"75 1","pages":"Pages 8-16"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10103548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.1016/j.otoeng.2023.06.006
Víctor Aparisi-Climent , José Miguel Sequi-Sabater , José Ignacio Collar-Del Castillo , José Miguel Sequi-Canet
The effect of hypoxia on the functioning of the outer hair cells of the cochlea, which are responsible for the response to otoemissions used in neonatal hearing screening, is well known.
The aim of this study is to determine the influence of mild to moderate variations in umbilical cord pH at birth on the outcome of hearing screening with otoemissions in healthy newborns without hearing risk factors.
The sample is composed of 4536 healthy infants. The results show no significant differences in the hearing screening outcome between the asphyctic (<7.20) and normal pH group. Nor is a figure below 7.20 detected in the sample that is related to an alteration in the screening.
When broken down into subgroups with known factors of variation in the screening result, such as gender or lactation, no significant differences in response were detected.
Apgar ≤7 is significantly related to pH < 7.20.
In conclusion, mild-moderate asphyxia associated with delivery of healthy newborns, without auditory risk factors, does not alter the outcome of otoemission screening.
{"title":"Influence of umbilical cord pH on the outcome of hearing screening with otoacoustic emissions in healthy newborns","authors":"Víctor Aparisi-Climent , José Miguel Sequi-Sabater , José Ignacio Collar-Del Castillo , José Miguel Sequi-Canet","doi":"10.1016/j.otoeng.2023.06.006","DOIUrl":"10.1016/j.otoeng.2023.06.006","url":null,"abstract":"<div><p>The effect of hypoxia<span><span> on the functioning of the outer hair cells of the cochlea, which are responsible for the response to otoemissions used in neonatal </span>hearing screening, is well known.</span></p><p><span>The aim of this study is to determine the influence of mild to moderate variations in umbilical cord<span> pH at birth on the outcome of hearing screening with otoemissions in healthy </span></span>newborns without hearing risk factors.</p><p>The sample is composed of 4536 healthy infants. The results show no significant differences in the hearing screening outcome between the asphyctic (<7.20) and normal pH group. Nor is a figure below 7.20 detected in the sample that is related to an alteration in the screening.</p><p>When broken down into subgroups with known factors of variation in the screening result, such as gender or lactation, no significant differences in response were detected.</p><p>Apgar ≤7 is significantly related to pH<!--> <!--><<!--> <!-->7.20.</p><p>In conclusion, mild-moderate asphyxia associated with delivery of healthy newborns, without auditory risk factors, does not alter the outcome of otoemission screening.</p></div>","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"75 1","pages":"Pages 1-7"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9735397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.1016/j.otoeng.2023.09.002
Christian Calvo-Henriquez , Byron Maldonado-Alvarado , Paula Rodriguez-Rivas , Miguel Rodriguez-Iglesias , Gabriel Martínez-Capoccioni , David Lobo , Carlos Martin-Martin , Isam Alobid
Despite the fact that turbinate surgery provides satisfactory results regarding nasal obstruction, most of these procedures are destructive, to some extent, for the respiratory epithelium. There are valid hypotheses suggesting either that turbinate surgery may improve mucociliary clearance (MCC) by improving rhinitis, as well hypotheses suggesting that these surgeries may impair it by damaging the nasal ciliated epithelia. This systematic review is designed with the objective of exploring the effect of turbinate surgery on MCC. Pubmed (Medline), the Cochrane Library, EMBASE, SciELO were analyzed. Four authors members of the YO-IFOS rhinology study group independently analyzed the articles. Extracted variables encompassed: sample size, age, indication for surgery, surgical technique, method used to measure mucociliary clearance, mucociliary transport time before and after surgery, and main outcome. 15 studies with a total population of 1936 participants (1618 patients excluding healthy controls) met the inclusion criteria. 9 studies could be combined in a metanalysis, wich revealed a non-statistically significant decrease of 3.86 min in MCTT after turbinate surgery (p = 0.06). The subgroup analysis of the 5 cohorts who underwent microdebrider turbinoplasty reached statistical significance under a random effect model, revealing a 7.02 min decrease in MCTT (p < 0.001). The laser turbinoplasty subgroup, composed of 4 cohorts, also reached significance, although the difference was lower than that for microdebrider turbinoplasty, 1.01 min (p < 0.001).
This systematic review and meta-analysis suggests that turbinate surgery does not compromise mucociliary clearance. The available evidence also suggests that turbinate surgery with mucosa sparing techniques improves MCC, while with aggressive techniques it increases or remains the same. This beneficial effect is evident since the first to third month after surgery. However, for solid conclusions, a standard way to measure MCTT should be stablished, as well as a method to appropriately describe the extension of the surgery.
{"title":"Effect of turbinate surgery on mucociliary clearance. A systematic review and metanalysis","authors":"Christian Calvo-Henriquez , Byron Maldonado-Alvarado , Paula Rodriguez-Rivas , Miguel Rodriguez-Iglesias , Gabriel Martínez-Capoccioni , David Lobo , Carlos Martin-Martin , Isam Alobid","doi":"10.1016/j.otoeng.2023.09.002","DOIUrl":"10.1016/j.otoeng.2023.09.002","url":null,"abstract":"<div><p><span><span><span><span>Despite the fact that turbinate surgery provides satisfactory results regarding nasal obstruction, most of these procedures are destructive, to some extent, for the </span>respiratory epithelium. There are valid hypotheses suggesting either that turbinate surgery may improve </span>mucociliary clearance<span> (MCC) by improving rhinitis<span>, as well hypotheses suggesting that these surgeries may impair it by damaging the nasal ciliated epithelia. This </span></span></span>systematic review<span> is designed with the objective of exploring the effect of turbinate surgery on MCC. Pubmed (Medline), the Cochrane Library, EMBASE, SciELO were analyzed. Four authors members of the YO-IFOS rhinology<span> study group independently analyzed the articles. Extracted variables encompassed: sample size, age, indication for surgery, surgical technique, method used to measure mucociliary clearance, mucociliary transport time before and after surgery, and main outcome. 15 studies with a total population of 1936 participants (1618 patients excluding healthy controls) met the inclusion criteria. 9 studies could be combined in a metanalysis, wich revealed a non-statistically significant decrease of 3.86 min in MCTT after turbinate surgery (</span></span></span><em>p</em> = 0.06). The subgroup analysis of the 5 cohorts who underwent microdebrider turbinoplasty reached statistical significance under a random effect model, revealing a 7.02 min decrease in MCTT (<em>p</em> < 0.001). The laser turbinoplasty subgroup, composed of 4 cohorts, also reached significance, although the difference was lower than that for microdebrider turbinoplasty, 1.01 min (<em>p</em> < 0.001).</p><p>This systematic review and meta-analysis suggests that turbinate surgery does not compromise mucociliary clearance. The available evidence also suggests that turbinate surgery with mucosa sparing techniques improves MCC, while with aggressive techniques it increases or remains the same. This beneficial effect is evident since the first to third month after surgery. However, for solid conclusions, a standard way to measure MCTT should be stablished, as well as a method to appropriately describe the extension of the surgery.</p></div>","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"75 1","pages":"Pages 47-60"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10311189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-01DOI: 10.1016/j.otoeng.2022.10.008
Faustino Núñez-Batalla , Carmen Jáudenes-Casaubón , Jose Miguel Sequí-Canet , Ana Vivanco-Allende , Jose Zubicaray-Ugarteche
Approximately 40% of children with deafness have an additional developmental disorder or major medical problem, which may delay the age of diagnosis of hearing loss and/or require intervention by other professionals. This situation is referred to as “deafness with added disability” (AD+). The reason why the population of hearing-impaired children is more likely to have associated added disabilities is that the risk factors for hearing impairment overlap with those for many other disabilities. These factors can influence various aspects of development, including language acquisition. It is important to check that appropriate care is received, the effectiveness of hearing aids or implants, as well speech therapy intervention strategies, and family adherence to sessions and appointments. The challenge posed by AD+ is early detection, to allow early and appropriate intervention, and the need for fluid transdisciplinary collaboration between all professionals involved, together with the involvement of the family.
{"title":"Deaf children with additional disabilities (AD+): CODEPEH recommendations","authors":"Faustino Núñez-Batalla , Carmen Jáudenes-Casaubón , Jose Miguel Sequí-Canet , Ana Vivanco-Allende , Jose Zubicaray-Ugarteche","doi":"10.1016/j.otoeng.2022.10.008","DOIUrl":"10.1016/j.otoeng.2022.10.008","url":null,"abstract":"<div><p>Approximately 40% of children with deafness have an additional developmental disorder or major medical problem, which may delay the age of diagnosis of hearing loss and/or require intervention by other professionals. This situation is referred to as “deafness with added disability” (AD+). The reason why the population of hearing-impaired children is more likely to have associated added disabilities is that the risk factors for hearing impairment overlap with those for many other disabilities. These factors can influence various aspects of development, including language acquisition. It is important to check that appropriate care is received, the effectiveness of hearing aids or implants, as well speech therapy intervention strategies, and family adherence to sessions and appointments. The challenge posed by AD+ is early detection, to allow early and appropriate intervention, and the need for fluid transdisciplinary collaboration between all professionals involved, together with the involvement of the family.</p></div>","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"74 6","pages":"Pages 386-396"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9500923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-01DOI: 10.1016/j.otoeng.2023.05.006
Xavier León , Sílvia Bagué , Anna Holgado , Miquel Quer , Ximena Terra , Mercedes Camacho , Francesc-Xavier Avilés-Jurado
Background
The altered cellular metabolism is one of the hallmarks of the cancer cells, favoring the process of aerobic glycolysis, known as the Warburg effect. The pyruvate dehydrogenase (PDH) complex is one of the elements involved in this metabolic process. The present study aims to evaluate the relationship between the transcriptional expression of PDHB and the risk of local recurrence in patients with oral cavity carcinomas.
Methods
We determined the transcriptional expression of PDHB in biopsies from 41 patients with oral cavity carcinomas treated with surgery. The PDHB expression was categorized according to the local control of the disease with a recursive partitioning analysis.
Results
During the follow-up period 13 patients (31.7%) had a local recurrence of the tumor. Considering local disease control as the dependent variable, the recursive partitioning analysis classified the patients in two categories according to high (n = 16, 39.0%) or low (n = 25, 61.0%) PDHB expression. Five-year local recurrence-free survival for patients with high PDHB expression was 84.8% (95% CI: 65.2-100%), and for patients with low expression it was 54.3% (95% CI: 34.3–74.2 %) (P = 0.034). The results of multivariate analysis showed that patients with a low PDHB expression had a 4.90 times higher risk of local recurrence of the tumor (95% CI: 1.02–22.68, P = 0.042).
Conclusion
There is a relationship between the metabolic characteristics of the tumor and its aggressiveness. According to our results, patients with oral cavity carcinomas with low transcriptional expression levels of PDHB have a significantly higher risk of local tumor recurrence.
{"title":"Relationship between transcriptional expression of pyruvate dehydrogenase and local control of disease in patients with oral cavity carcinomas","authors":"Xavier León , Sílvia Bagué , Anna Holgado , Miquel Quer , Ximena Terra , Mercedes Camacho , Francesc-Xavier Avilés-Jurado","doi":"10.1016/j.otoeng.2023.05.006","DOIUrl":"10.1016/j.otoeng.2023.05.006","url":null,"abstract":"<div><h3>Background</h3><p><span>The altered cellular metabolism is one of the hallmarks of the cancer cells, favoring the process of </span>aerobic glycolysis<span><span>, known as the Warburg effect. The pyruvate dehydrogenase (PDH) complex is one of the elements involved in this metabolic process. The present study aims to evaluate the relationship between the transcriptional expression of PDHB and the risk of local recurrence </span>in patients<span> with oral cavity carcinomas.</span></span></p></div><div><h3>Methods</h3><p>We determined the transcriptional expression of PDHB in biopsies from 41 patients with oral cavity carcinomas treated with surgery. The PDHB expression was categorized according to the local control of the disease with a recursive partitioning analysis.</p></div><div><h3>Results</h3><p>During the follow-up period 13 patients (31.7%) had a local recurrence of the tumor. Considering local disease control as the dependent variable, the recursive partitioning analysis classified the patients in two categories according to high (n<!--> <!-->=<!--> <!-->16, 39.0%) or low (n<!--> <!-->=<!--> <!-->25, 61.0%) PDHB expression. Five-year local recurrence-free survival for patients with high PDHB expression was 84.8% (95% CI: 65.2-100%), and for patients with low expression it was 54.3% (95% CI: 34.3–74.2 %) (P<!--> <!-->=<!--> <span>0.034). The results of multivariate analysis showed that patients with a low PDHB expression had a 4.90 times higher risk of local recurrence of the tumor (95% CI: 1.02–22.68, P</span> <!-->=<!--> <!-->0.042).</p></div><div><h3>Conclusion</h3><p>There is a relationship between the metabolic characteristics of the tumor and its aggressiveness. According to our results, patients with oral cavity carcinomas with low transcriptional expression levels of PDHB have a significantly higher risk of local tumor recurrence.</p></div>","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"74 6","pages":"Pages 372-378"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41163989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}